About the journal
Endocrine Related Cancer is a journal published by Bioscientifica in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Bioscientifica
- ISSN
- 1351-0088 · 1479-6821
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://erc.endocrinology-journals.org
Index listings
- MEDLINE · 1999-01-01
- PUBMED · 2016-06-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 153 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2843
Last recorded publication year
2026
h-index
172
i10-index
2140
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 95%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9436481
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Adrenal and Paraganglionic Tumors
- Adrenal and Paraganglionic Tumors
Show all subjects (50)
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Pituitary Gland Disorders and Treatments
- Pituitary Gland Disorders and Treatments
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Growth Hormone and Insulin-like Growth Factors
- Growth Hormone and Insulin-like Growth Factors
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Hormonal Regulation and Hypertension
- Hormonal Regulation and Hypertension
- BRCA gene mutations in cancer
- Pancreatic and Hepatic Oncology Research
- BRCA gene mutations in cancer
- Cancer Risks and Factors
- Cancer Risks and Factors
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cancer, Lipids, and Metabolism
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
- Breast Cancer Treatment Studies
- Thyroid Disorders and Treatments
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Cytokine Signaling Pathways and Interactions
- Epigenetics and DNA Methylation
- Cytokine Signaling Pathways and Interactions
- Epigenetics and DNA Methylation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ